Objectives

After participating in this educational activity, attendees should be able to:
1. Review GLP-1 receptor agonists background and place in therapy for treatment of Type 2 diabetes
2. Discuss primary literature regarding efficacy and safety of oral semaglutide in patients with Type 2 diabetes
3. Identify which patients may be appropriate candiates for oral GLP-1RA therapy.

 
Faculty

Kelsey Leite, PharmD 
PGY1 Community-Based Pharmacy Resident
Pharmacist
Baystate Medical Center 

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

 

Session date: 
Monday, December 2, 2019 - 2:00pm to 3:00pm
Location: 
Baystate Medical Center
759 Chestnut Street
MM7
Springfield, MA 01199
United States
  • 1.00 ACPE Contact Hours

Please login or register to take this course.